Jounce Therapeutics Inc (JNCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Operating Expenses | 31,661 | 31,405 | 33,714 | 37,462 | 30,282 |
| Operating Income | 50,339 | -31,405 | -33,714 | -37,462 | -30,282 |
| Other Income | 737 | 412 | 213 | 96 | 55 |
| Pre-tax Income | 51,076 | -30,993 | -33,501 | -37,366 | -30,227 |
| Income Tax | 117 | 5 | 12 | 1 | 6 |
| Net Income Continuous | 50,959 | -30,998 | -33,513 | -37,367 | -30,233 |
| Net Income | $50,959 | $-30,998 | $-33,513 | $-37,367 | $-30,233 |
| EPS Basic Total Ops | 0.98 | -0.60 | -0.65 | -0.72 | -0.57 |
| EPS Basic Continuous Ops | 0.99 | -0.60 | -0.65 | -0.72 | -0.58 |
| EPS Diluted Total Ops | 0.98 | -0.60 | -0.65 | -0.72 | -0.57 |
| EPS Diluted Continuous Ops | 0.99 | -0.60 | -0.65 | -0.72 | -0.58 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.60 | -0.65 | -0.72 | -0.59 |
| EBITDA(a) | $-31,064 | $-30,686 | $-32,931 | $-36,571 | $-29,322 |